News
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Radius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Real-world data analysis shows TYMLOS® demonstrates lower hip and non-vertebral fracture rates than teriparatide in women with osteoporosis 50+, with balanced cardiovascular events. Presented at WCO-IOF-ESCEO -
-